Medtronic plc. (MDT) financial statements and ratios from SEC XBRL: revenue $37.5B (TTM), net margin 13.2%, revenue growth 13.7% YoY, P/E 22.2. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $36.36B |
| Revenue (TTM) | $37.5B |
| Net Margin | 13.2% |
| Return on Equity | 10.4% |
| Operating Margin (TTM) | 18.1% |
| Debt / Equity | 0.55 |
| Current Ratio | 2.07 |
| Net Debt / EBITDA | 2.0 |
| Interest Coverage | 9.4 |
| Revenue Growth (YoY) | 13.7% |
| EPS Growth (YoY) | 42.0% |
| FCF Growth (YoY) | 120.9% |
| P/E Ratio | 22.2 |
| EV / EBITDA | 14.7 |
| Price / Book | 2.29 |
| Price / Sales | 3.10 |
| Dividend Yield | 3.1% |
| FCF Yield | 5.3% |
| Altman Z-Score | 2.91 (grey) |
| Piotroski F-Score | 8/9 |
| Piotroski checks passed | 8 of 9 |
| Industry P/E (Medical Equipment) | 27.4 |
| Sector P/E (Healthcare) | 19.4 |
MDT overview · MDT earnings · MDT KPIs · MDT documents · MDT ownership · MDT peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.